Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 17, 2021

Total Value: $994M (100.0% shares, 0.0% debt)

Holdings (43)

Jiya Acquisition Corp 51.0%
Value $507M Shares 5,223 Est. Cost $97078.50 Unrealized
NKTX Nkarta, Inc. 12.6%
Value $125M Shares 2,034,703 Est. Cost $29.47 Unrealized +40.9%
Chinook Therapeutics Inc 5.1%
Value $50.25M Shares 3,168,388 Est. Cost $15.86 Unrealized
Forma Therapeutics Holdings, Inc. 5.0%
Value $49.51M Shares 1,418,529 Est. Cost $46.49 Unrealized
Sutro BioPharma Inc 3.7%
Value $36.38M Shares 1,675,579 Est. Cost $8.61 Unrealized
Syros Pharmaceuticals Inc 2.2%
Value $21.84M Shares 2,189,199 Est. Cost $7.95 Unrealized
Allakos Inc 2.1%
Value $20.48M Shares 146,259 Est. Cost $51.45 Unrealized
Springworks Therapeutics Inc 1.9%
Value $19.04M Shares 262,572 Est. Cost $21.68 Unrealized
Iveric Bio, Inc. 1.6%
Value $16.4M Shares 2,372,476 Est. Cost $5.74 Unrealized
Odonate Therapeutics Inc 1.6%
Value $15.66M Shares 815,421 Est. Cost $14.27 Unrealized
Intercept Pharmaceuticals Inc 1.0%
Value $9.971M Shares 403,688 Est. Cost $88.27 Unrealized
ACRS Aclaris Therapeutics, Inc. 0.9%
Value $8.816M Shares 1,362,612 Est. Cost $1.36 Unrealized +209.9%
Verona Pharma PLC. 0.8%
Value $7.778M Shares 1,111,112 Est. Cost $6.18 Unrealized
CureVac N.V. 0.8%
Value $7.727M Shares 95,318 Est. Cost $46.55 Unrealized
Atreca Inc 0.8%
Value $7.67M Shares 474,943 Est. Cost $17.99 Unrealized
Aeglea BioTherapeutics, Inc. 0.7%
Value $6.955M Shares 883,720 Est. Cost $9.25 Unrealized
COGT Cogent Biosciences Inc 0.7%
Value $6.614M Shares 588,961 Est. Cost $10.99 Unrealized 0.0%
RYTM Rhythm Pharmaceuticals Inc 0.6%
Value $5.977M Shares 201,046 Est. Cost $17.90 Unrealized +42.0%
EQ Equillium, Inc. 0.6%
Value $5.747M Shares 1,074,285 Est. Cost $8.10 Unrealized -35.5%
BCTG Acquisition Corp 0.6%
Value $5.72M Shares 500,000 Est. Cost $10.36 Unrealized
Panacea Acquisition Corp. 0.5%
Value $5.104M Shares 400,000 Est. Cost $12.00 Unrealized
Alpine Immune Sciences Inc 0.5%
Value $5.03M Shares 399,190 Est. Cost $8.79 Unrealized
Kronos Bio Inc 0.5%
Value $4.966M Shares 166,250 Est. Cost $29.87 Unrealized
Kala Pharmaceuticals Inc 0.4%
Value $4.076M Shares 601,162 Est. Cost $8.83 Unrealized
Albireo Pharma, Inc. 0.4%
Value $3.751M Shares 100,000 Est. Cost $33.37 Unrealized
RCKT Rocket Pharmaceuticals Inc 0.4%
Value $3.497M Shares 63,770 Est. Cost $19.67 Unrealized +85.3%
FULC Fulcrum Therapeutics, Inc. 0.3%
Value $3.444M Shares 294,118 Est. Cost $15.75 Unrealized -28.2%
NVAX Novavax, Inc. 0.3%
Value $3.363M Shares 30,160 Est. Cost $117.44 Unrealized -9.5%
BCLS Acquisition Corp 0.3%
Value $3.342M Shares 300,000 Est. Cost $11.14 Unrealized
Vistagen Therapeutics Inc 0.3%
Value $3.182M Shares 1,640,368 Est. Cost $1.94 Unrealized
Allovir, Inc 0.3%
Value $3.165M Shares 82,336 Est. Cost $27.50 Unrealized
Consonance HFW Acquisition Co 0.3%
Value $3.141M Shares 300,000 Est. Cost $10.47 Unrealized
Avadel Pharmaceuticals PLC 0.3%
Value $2.901M Shares 434,250 Est. Cost $6.68 Unrealized
Lifesci Acquisition II Corp 0.2%
Value $2.134M Shares 200,000 Est. Cost $10.67 Unrealized
GERN Genron Corporation 0.2%
Value $1.948M Shares 1,224,870 Est. Cost $1.49 Unrealized +21.9%
Hookipa Pharma Inc 0.1%
Value $1.438M Shares 129,660 Est. Cost $7.17 Unrealized
KALV KalVista Pharmaceuticals Inc 0.1%
Value $1.277M Shares 67,270 Est. Cost $18.15 Unrealized -5.5%
SPRY Silverback Therapeutics Inc 0.1%
Value $1.159M Shares 25,000 Est. Cost $33.40 Unrealized 0.0%
BNTX BioNTech SE 0.1%
Value $880K Shares 10,795 Est. Cost $69.21 Unrealized
Kadmon Hldgs Inc 0.1%
Value $685K Shares 165,000 Est. Cost $4.15 Unrealized
Catabasis Pharmaceuticals Inc 0.1%
Value $642K Shares 300,000 Est. Cost $4.37 Unrealized
NGM Biopharmaceuticals, Inc. 0.1%
Value $552K Shares 18,225 Est. Cost $19.73 Unrealized
Amarin Corp PLC 0.0%
Value $122K Shares 25,000 Est. Cost $4.00 Unrealized